Trial in Progress: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Treated with ≥1 Prior Tyrosine Kinase Inhibitor

Hijiya, N., Kapoor, S., Descamps, L., Bayar, M. A., & Ramscar, N. (2021). Trial in Progress: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Treated with ≥1 Prior Tyrosine Kinase Inhibitor. Blood, 138(Supplement 1), 2561–2561. https://doi.org/10.1182/blood-2021-151198

Authors:

Nobuko Hijiya

S. S. Kapoor

Laurence Descamps

Mohamed Amine Bayar

Nicholas Ramscar

Affiliated Authors:

Nobuko Hijiya

Columbia Affiliation: